title: Managing attention-deficit/hyperactivity disorder in children and adolescents.
abstract: Attention-deficit/hyperactivity disorder (ADHD) is the most frequently diagnosed neurodevelopmental disorder; 6.4 million children and adolescents have been diagnosed with ADHD as of 2011. However, only 3.5 million children and adolescents are taking medication for ADHD. Adolescents with ADHD are much less willing to pursue or adhere to medication or psychosocial therapy, often because of their perceptions of side effects or perceived value of treatment, which places them at greater risk for difficulties at school, work, and home environments. Providing adolescents with increased autonomy through patient-centered approaches can increase their involvement and ability to manage their ADHD symptoms and treatment.
authors: Department of Primary Care Medicine, Kansas City University of Medicine and Biosciences College of Osteopathic Medicine, 1750 Independence Avenue, Kansas City, MO 64106, USA. Electronic address: emcclain@kcumb.edu.
authors: Elizabeth K
authors: EK
authors: McClain
authors: Department of Psychiatry, School of Medicine, University of Missouri-Kansas City, 1000 E. 24th Street, Kansas City, MO 64108, USA.
authors: Erin Jewell
authors: EJ
authors: Burks
mesh_terms: D000293:Adolescent; D058647:Adrenergic alpha-2 Receptor Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis* / Q000188:drug therapy*; D001521:Behavior Therapy; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D054626:Consumer Health Information; D003657:Decision Making; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D011320:Primary Health Care; D019966:Substance-Related Disorders / Q000453:epidemiology
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D000697:Central Nervous System Stimulants
keywords: Adolescents; Attention-deficit/hyperactivity disorder; DSM-V; Nonpharmacologic approaches; Nonstimulant medication; Pharmacologic approaches; Shared decision making; Stimulant medication